Understanding the real-world clinical effectiveness of pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) (ISPOR 2023 PNH) - Apellis Medical Hub

Understanding the real-world clinical effectiveness of pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)

Share Via Email

Back to Conference Resources

PNH Congress Presentations International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.